Methods to assess neuroinflammation

Current Protocols in Toxicology

Volumn , Issue SUPPL.50, 2011, Pages

  Monnet Tschudi, Florianne ^a,b   Defaux, Antoinette ^a,b   Braissant, Olivier ^c   Cagnon, Laurène ^c   Zurich, Marie Gabrielle ^a,b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b Swiss Centre for Applied Human Toxicology   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Astrocyte; Chemokine; Cytokine; Microglia; Neuroinflammation

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 6; ISOLECTIN B4; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; RANTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL INTERACTION; CELL LABELING; CELL MATURATION; ENCEPHALITIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION SYSTEM; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MICROGLIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 84857567699     PISSN: 19349254     EISSN: 19349262     Source Type: Journal    
DOI: 10.1002/0471140856.tx1219s50     Document Type: Article

References (46)

1. Aldridge, G.M., Podrebarac, D.M. Greenough, W.T., and Weiler, I.J. 2008. The use of total protein stains as loading controls: An alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. J. Neurosci. Methods 172:250-254.
2. Aschner, M. 1998. Astrocytes as mediators of immune and inflammatory responses in the CNS. NeuroToxicology 19:269-281.
3. Bianco, F., Pravettoni, E., Colombo, A., Schenk, U., Moller, T., Matteoli, M., and Verderio, C. 2005. Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J. Immunol. 174:7268-7277.
4. Defaux, A., Zurich, M.G., Braissant, O., Honegger, P., and Monnet-Tschudi, F. 2009. Effects of the PPAR-beta agonist GW501516 in an in vitro model of brain inflammation and antibodyinduced demyelination. J. Neuroinflammation 6:15.
5. Defaux, A., Zurich, M-G., Honegger, P., and Monnet-Tschudi, F. 2010. Inflammatory responses in aggregating rat brain cell cultures subjected to different demyelinating conditions. Brain Res. 1353:213-224.
6. Defaux, A., Zurich, M.G., Honegger, P., and Monnet-Tschudi, F. 2011. Minocycline promotes remyelination in aggregating rat brain cell cultures after interferon-gamma plus lipopolysaccharide-induced demyelination. Neuroscience 187:84-92.
7. Dong, Y. and Benveniste, E.N. 2001. Immune function of astrocytes. Glia 36:180-190.
8. Eng, L.F., Ghirnikar, R.S., and Lee, Y.L. 2000. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem. Res. 25:1439-1451.
9. Eskes, C., Honegger, P., Juillerat-Jeanneret, L., and Monnet-Tschudi, F. 2002. Microglial reaction induced by noncytotoxic methylmercury treatment leads to neuroprotection via interactions with astrocytes and IL-6 release. Glia 37:43-52
10. Eskes, C., Juillerat-Jeanneret, L., Leuba,G., Honegger, P., and Monnet-Tschudi, F. 2003. Involvement of microglia-neuron interactions in the tumor necrosis factor-alpha release, microglial activation, and neurodegeneration induced by trimethyltin. J. Neurosci. Res. 71:583-590.
11. Fraga, D., Meulia, T., and Fenster, S. 2008. Realtime PCR. Curr. Protoc. Essent. Lab. Tech. 00:10.3.1-10.3.34.
12. Gallagher, S.R. 2010. Protein blotting: Immunoblotting. Curr. Protoc. Essent. Lab. Tech. 4:8.3.1-8.3.36.
13. Gomez-Nicola, D., Valle-Argos, B., Pita-Thomas, D.W. andNieto-Sampedro, M. 2008. Interleukin 15 expression in the CNS: Blockade of its activity prevents glial activation after an inflammatory injury. Glia 56:494-505.
14. Griffin, W.S., Sheng, J.G., Royston, M.C., Gentleman, S.M.,McKenzie, J.E.,Graham, D.I., Roberts, G.W., and Mrak, R.E. 1998. Glialneuronal interactions in Alzheimer's disease: The potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 8:65-72.
15. Gruol, D.L. and Nelson, T.E. 1997. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol. 15:307-339.
16. Hanisch, U.K. and Kettenmann, H. 2007. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10:1387-1394.
17. Hemmer, B., Cepok, S., Nessler, S., and Sommer, N. 2002. Pathogenesis of multiple sclerosis: An update on immunology. Curr. Opin. Neurol. 15:227-231.
18. Herlaar, E. and Brown, Z. 1999. p38 MAPK signalling cascades in inflammatory disease. Mol. Med. Today 5:439-447.
19. Hoffman, G.E., Le, W.W. and Sita, L.V. 2008. The importance of titrating antibodies for immunocytochemical methods. Curr. Protoc. Neurosci. 45:2.12.1-2.12.26.
20. Honegger, P. and Monnet-Tschudi, F. 2001. Aggregating neural cell cultures. In Protocols for Neural Cell Culture, 3rd ed. (Fedoroff, S. and Richardson, A., eds) pp. 199-218. Humana Press, Totowa, N.J.
21. Honegger, P., Lenoir, D., and Favrod, P. 1979. Growth and differentiation of aggregating fetal rat brain cells in a serum-free defined medium. Nature 282:305-308.
22. Honegger, P., Monnet-Tschudi, F., and Zurich, M.-G. 2010. Aggregating brain cell cultures for neurotoxicity tests. In Methods in Bioengineering. Alternative Technologies to Animal Testing (T. Maguire and E. Novik, eds.) pp 41-60. Artech House, Norwood, Mass.
23. Kreutzberg, G.W. 1996. Microglia: A sensor for pathological events in the CNS. Trends Neurosci. 19:312-318.
24. -ΔΔCT method. Methods 25:402-408.
25. Mandell, J.W. and VandenBerg, S.R. 1999. ERK/MAP kinase is chronically activated in human reactive astrocytes. Neuroreport 10:3567-3572.
26. Mandell, J.W., Gocan, N.C., and Vandenberg, S.R. 2001. Mechanical trauma induces rapid astroglial activation of ERK/MAP kinase: Evidence for a paracrine signal. Glia 34:283-295.
27. Maruyama, M., Sudo, T., Kasua, Y., Shiga, T., Hu, B.-R., and Osada, H. 2000. Immunolocalization of p38 MAP kinase in mouse brain. Brain Res. 887:350-358.
28. Monnet-Tschudi, F., Zurich, M.G., Pithon, E., van Melle, G., and Honegger, P. 1995a. Microglial responsiveness as a sensitive marker for trimethyltin (TMT) neurotoxicity. Brain Res. 690:8-14.
29. Monnet-Tschudi, F., Zurich, M.G., Riederer, B.M., and Honegger, P. 1995b. Effects of trimethyltin (TMT) on glial and neuronal cells in aggregate cultures: Dependence on the developmental stage. NeuroToxicology 16:97-104.
30. Monnet-Tschudi, F., Zurich, M.G., and Honegger, P. 1996. Comparison of the developmental effects of two mercury compounds on glial cells and neurons in aggregate cultures of rat telencephalon. Brain Res. 741:52-59.
31. Monnet-Tschudi, F., Zurich, M.G., Boschat, C., Corbaz, A., and Honegger, P. 2006. Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases. Rev. Environ. Health 21:107-119.
32. Monnet-Tschudi, F., Zurich, M.-G., and Honegger, P. 2007. Neurotoxicant-induced inflammatory response in three-diemensional brain cell cultures. Hum. Exp. Toxicol. 26:339-346.
33. Monnet-Tschudi, F., Defaux, A., and Zurich, M.-G. 2010. Probable involvement of heavy metal-induced neuroinflammation in neurodegeneration. In Metals and Neurodegeneration. (S. Huang, ed.) pp. 1-14. Research Signpost, Trivandrum, Kerala, India.
34. Munoz-Fernandez, M.A. and Fresno, M. 1998. The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog. Neurobiol. 56:307-340.
35. O'Neill, L.A.J. and Kaltschmidt, C. 1997. NFkappaB: A crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20:252-258.
36. Ortinski, P.I., Dong, J., Mungenast, A., Yue, C., Takano, H., Watson, D.J., Haydon, P.G., and Coulter, D.A. 2010. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat. Neurosci. 13:584-591.
37. Piao, C.S., Che, Y., Han, P.L. and Lee, J.K. 2002. Delayed and differential induction of p38 MAPK isoforms in microglia and astrocytes in the brain after transient global ischemia. Brain Res. Mol. Brain Res. 107:137-144.
38. Pinteaux, E., Parker, L.C., Rothwell, N.J., and Luheshi, G.N. 2002. Expression ofinterleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J. Neurochem. 83:754-763.
39. Ransohoff, R.M. andTani, M. 1998.Dochemokines mediate leukocyte recruitment in posttraumatic CNS inflammation? TINS 21:154-159.
40. Shideman, C.R., Hu, S., Peterson, P.K., and Thayer, S.A. 2006. CCL5 evokes calcium signals in microglia through a kinase-, phosphoinositide-, and nucleotide-dependent mechanism. J. Neurosci. Res. 83:1471-1484.
41. Sofroniew, M.V. 2005. Reactive astrocytes in neural repair and protection. Neuroscientist 11:400-407.
42. Streit, W.J., Walter, S.A., and Pennell, N.A. 1999. Reactive microgliosis. Prog. Neurobiol. 57:563-581.
43. Svensson, M., Eriksson, N.P., and Aldskogius, H. 1993. Evidence for activation of astrocytes via reactive microglial cells following hypoglossal nerve transection. J. Neurosci. 35:373-381.
44. Walton, K.M., DiRocco, R., Bartlett, B.A., Koury, E., Marcy, V.R., Jarvis, B., Schaefer, E.M., and Bhat,R.V. 1998. Activation pf p38MAPKin microglia after ischemia. J. Neurochem. 70:1764-1767.
45. Zurich, M.-G., Eskes, C., Honegger, P., Bérode, M., and Monnet-Tschudi, F. 2002. Maturation-dependent neurotoxicity of lead acetate in vitro: Implication of glial reactions. J. Neurosci. Res. 70:108-116.
46. Zurich, M.G., Honegger, P., Schilter, B., Costa, L.G., and Monnet-Tschudi, F. 2004. Involvement of glial cells in the neurotoxicity of parathion and chlorpyrifos. Toxicol. Appl. Pharmacol. 201:97-104.